AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 18, 2016
5262_dirs_2016-07-18_821aa711-5b8c-4f76-88b8-226093b97b22.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5139E
GlaxoSmithKline PLC
18 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mrs K Thomson
b)
Position/status
PCA of Mr P C Thomson (SVP, Communications & Government Affairs)
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £16.6781 | 102.401 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-14
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEVLFFQDFZBBX
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'-ORTpdagJ6xLM4yTooqc1MwT9RKlxK6QzJJTCZ9OkVcdFIZQS2t1wofTIZkEz1E7EmdWAdDRxt-kuLaKUKappUPxi4hl1jkKIHCNEG1_Z6Y1:8VjcOU8NVoCX-mIGMhOP-XysGIvorG1UNI4LST-BtPFEk806Y8CDK5ZMYi3k1GrCv8oOTlCdVuiBIXVLMiMbP_wYo49eRmzSLOgJ1VHocaE1'}});//]]>